Welcome to LookChem.com Sign In|Join Free
  • or
(1S,5R)-3-(2-Aza-bicyclo[3.3.1]non-5-yl)-phenol is a complex organic compound with a unique molecular structure. It is characterized by a phenol group attached to a 2-aza-bicyclo[3.3.1]nonane ring system, which is a nitrogen-containing bicyclic structure. (1S,5R)-3-(2-Aza-bicyclo[3.3.1]non-5-yl)-phenol is a chiral molecule, meaning it has a non-superimposable mirror image, with the specific configuration at the chiral centers being 1S and 5R. It is likely to have applications in the fields of pharmaceuticals, agrochemicals, or as a building block in organic synthesis due to its structural diversity and potential for functional group manipulation. The compound's properties, such as solubility, reactivity, and potential biological activity, would be influenced by its stereochemistry and the presence of the phenol and azabicyclo moieties.

51264-10-9

Post Buying Request

51264-10-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51264-10-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 51264-10-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,2,6 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 51264-10:
(7*5)+(6*1)+(5*2)+(4*6)+(3*4)+(2*1)+(1*0)=89
89 % 10 = 9
So 51264-10-9 is a valid CAS Registry Number.

51264-10-9Downstream Products

51264-10-9Relevant academic research and scientific papers

2-AZABICYCLO[3.3.1]NONANE DERIVATIVES AS OPIOID RECEPTOR ANTAGONISTS

-

Page 20, (2008/06/13)

The subject invention relates to 2-azabicyclo[3.3.1 ]nonane derivatives, pharmaceutical compositions comprising such derivatives and methods of using such derivatives to treat disease states, disorders and conditions mediated by opioid receptors. The subj

Probes for narcotic receptor mediated phenomena. Part 28: New opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphan

Hashimoto, Akihiro,Jacobson, Arthur E,Rothman, Richard B,Dersch, Christina M,George, Clifford,Flippen-Anderson, Judith L,Rice, Kenner C

, p. 3319 - 3329 (2007/10/03)

Enantiomeric analogues of 5-(3-hydroxyphenyl)morphan ligands were synthesized and evaluated because of our unexpected finding that opioid antagonists can be obtained in the 5-phenylmorphan series of opioids without sterically hindering the rotation of the phenolic ring. We determined the opioid receptor binding affinity of these new analogues, as well as the efficacy of the more interesting ligands. One of the new compounds [(1R,5S)-(-)-3-[2-(3′- phenylpropyl)-2-azbicyclo[3.3.1]non-5-yl]-phenol, 15] was found to have half of the efficacy of naloxone, a potent opioid antagonist, in the [35 S]GTPγS assay, and two others (1R,5S)-(-)-3-[2-(4′ -- phenylbutyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol, 17, and (1R,5S,1′S)- (+)-3-[2-(1′-methyl-2′-phenylethyl)-2-azabicyclo[3.3.1] non-5-yl]-phenol 26, acted as moderately potent opioid antagonists. X-ray crystallographic structure data were obtained on three compounds. Two of them had three chiral centers; 25 [(1R,5S,1′ R)-(-)-3-[2-(1′-methyl-2′-phenylethyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol] was determined to have the 1R,5,S,1′R configuration, and 26 the 1R,5S,1′S configuration. Since (1S,5R)-(+)-2-bromo-5-[2-(2′-phenylethyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol (32) was a position isomer of (1S,5R)-(+)-4-bromo-3-[ 2-(2′ -phenylethyl)-2-azabicyclo[3.3.1]non-5-yl]-phenol (30), and both showed the same 1 H NMR spectrum, the structure of 32 was unequivocally determined by X-ray structure analysis. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 51264-10-9